Publication Type:

Journal Article

Source:

The Lancet Oncology, Lancet Publishing Group, Volume 15, Number 5, p.489-538 (2014)

URL:

https://www.scopus.com/inward/record.url?eid=2-s2.0-84898041689&partnerID=40&md5=f6417959297c59a8b455616b07e6ec61

Keywords:

amrubicin, antineoplastic agent, bevacizumab, cyclophosphamide, eribulin, everolimus, herbaceous agent, lapatinib, lenalidomide, melphalan, trastuzumab

Abstract:

<p>Cancer is one of the major non-communicable diseases posing a threat to world health. Unfortunately, improvements in socioeconomic conditions are usually associated with increased cancer incidence. In this Commission, we focus on China, India, and Russia, which share rapidly rising cancer incidence and have cancer mortality rates that are nearly twice as high as in the UK or the USA, vast geographies, growing economies, ageing populations, increasingly westernised lifestyles, relatively disenfranchised subpopulations, serious contamination of the environment, and uncontrolled cancer-causing communicable infections. We describe the overall state of health and cancer control in each country and additional specific issues for consideration: for China, access to care, contamination of the environment, and cancer fatalism and traditional medicine for India, affordability of care, provision of adequate health personnel, and sociocultural barriers to cancer control; and for Russia, monitoring of the burden of cancer, societal attitudes towards cancer prevention, effects of inequitable treatment and access to medicine, and a need for improved international engagement. © 2014 Elsevier Ltd.</p>

Cite this Research Publication

P. Eae Goss, Strasser-Weippl, Kb, Lee-Bychkovsky, B. Lac f, Fan, Lfg, Li, Jfg, Chavarri-Guerra, Yfh, Liedke, P. E. Rfi, Pramesh, C. Sj, Badovinac-Crnjevic, Tfo, Sheikine, Yad, Chen, Zp, Qiao, Y. - Lq, Shao, Zg, Wu, Y. - Ls, Fan, Dt, Chow, L. W. Cuv, Wang, Jw, Zhang, Qx, Yu, Sy, Shen, Gzaa, He, Jr, Purushotham, Aab, Sullivan, Rabac, Badwe, Rk, Banavali, S. Dl, Nair, Rad, Kumar, Lae, Parikh, Paf, Subramanian, Sag, Chaturvedi, Pm, Iyer, Sah, Shastri, S. Sn, Digumarti, Rai, Soto-Perez-de-Celis, Eh, Adilbay, Daj, Semiglazov, Vak, Orlov, Sal, Kaidarova, Dam, Tsimafeyeu, Ian, Tatishchev, Sao, Danishevskiy, K. Dap, Hurlbert, Maq, Vail, Cf, St Louis, Jf, and Chan, Aar, “Challenges to effective cancer control in China, India, and Russia”, The Lancet Oncology, vol. 15, pp. 489-538, 2014.

207
PROGRAMS
OFFERED
6
AMRITA
CAMPUSES
15
CONSTITUENT
SCHOOLS
A
GRADE BY
NAAC, MHRD
8th
RANK(INDIA):
NIRF 2018
150+
INTERNATIONAL
PARTNERS
  • Amrita on Social Media

  • Contact us

    Amrita Vishwa Vidyapeetham,
    Amritanagar,
    Coimbatore - 641 112,
    Tamil Nadu, India.
    • Fax                 : +91 (422) 268 6274
    • Coimbatore   : +91 (422) 268 5000
    • Amritapuri    : +91 (476) 280 1280
    • Bengaluru     : +91 (080) 251 83700
    • Kochi              : +91 (484) 280 1234
    • Mysuru          : +91 (821) 234 3479
    • Chennai         : +91 (44 ) 276 02165
    • Contact Details »